FDA Adverse Event Malfunction Summary report: N

PREMICATH

MDR report key: 22642057 · Received July 29, 2025

Report

Report Number
2245270-2025-00080
Event Type
Malfunction
Date Received
July 29, 2025
Date of Event
February 19, 2025
Report Date
September 15, 2025
Manufacturer
VYGON USA
Product Code
LJS
PMA / PMN Number
K041468
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
NURSE
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE INVESTIGATION SUMMARY IS AS FOLLOWS: WE RECEIVED THE CATHETER AS FAULTY SAMPLE. A NON-VYGON GERMANY GMBH NEEDLE-FREE DEVICE WAS CONNECTED TO THE CATHETER'S LL HUB, AND THE CATHETER TUBE WAS SHORTENED AT THE 10 CM MARKING. THE ATTEMPT TO FLUSH THE CATHETER WITH WATER WAS SUCCESSFUL, AND LEAKAGE WAS DETECTED AT THE JUNCTION BETWEEN THE CATHETER TUBE AND THE EXTENSION LINE. MICROSCOPIC EXAMINATION REVEALED A LARGE TEAR/HOLE WITH A VERY ROUGH, JAGGED FRACTURE SURFACE AND SIGNS OF STRESS WHITENING, INDICATING EXPOSURE TO EXCESSIVE TENSILE FORCE. IN GENERAL, THERE ARE VARIOUS EVENTS THAT CAN LEAD TO A LEAKING CATHETER: 1. TENSILE FORCE. WHICH MAY BE CAUSED BY: - DRESSING CHANGE - IN SOME INSTANCES THE CATHETER CAN BECOME ADHERED TO THE DRESSING AND ADDITIONAL PULLING IS REQUIRED TO FREE IT; PLACING STRESS ON THE LINE COULD RESULT IN A TENSILE FRACTURE. - FOR BABIES, ROUTINE CARE (WHEN LIFTING THE BABY TO CHANGE THE BEDDING) AND MOVEMENT OF THE BABY ITSELF COULD RESULT IN A TENSILE FRACTURE. 2. MECHANICAL DAMAGE BY A SHARP INSTRUMENT (FOR EXAMPLE SCISSORS, TOOTHED FORCEPS OR SCALPEL) DURING DRESSING CHANGE. 3. ALCOHOL-BASED DISINFECTANT. CONCERNING THIS, THERE ARE SOME WARNINGS IN THE IFU: "BE AWARE THAT ORGANIC SOLVENTS SUCH AS ALCOHOL OR ACETONE MAY INTERACT WITH CATHETER MATERIAL AND WEAKEN IT." AND "AVOID ANY CONTACT OF THE CATHETER TUBING TO ALCOHOL CONTAINING DISINFECTANTS. THIS MAY IRREVERSIBLY DAMAGE THE CATHETER. THE CUSTOMER STATED IN THE PIR THAT AN ALCOHOL-BASED DISINFECTANT WAS USED. IN ADDITION, A MANUFACTURING DEFECT CAN BE RULED OUT, AS EACH CATHETER UNDERGOES FLOW AND LEAK TESTING DURING PRODUCTION. FURTHERMORE, ACCORDING TO THE CUSTOMER, THE CATHETER FUNCTIONED WITHOUT LEAKAGE FOR EIGHT DAYS, AND AN ALCOHOL-BASED DISINFECTANT WAS USED. A REVIEW OF THE COMPONENT BATCH HISTORY RECORDS; NO DEVIATIONS WERE FOUND. THE BATCH COMPLIED WITH ITS SPECIFICATION AND WAS RELEASED ACCORDINGLY. EACH CATHETER IS FLOW AND LEAK TESTED DURING PRODUCTION. THE TENSILE FORCE AND DIMENSIONS OF CATHETER AND SET COMPONENTS ARE RANDOMLY CHECKED AS PART OF QUALITY CONTROL PROCESS. A TWO-YEAR REVIEW OF VYGON USA'S COMPLAINT DATA IDENTIFIED SIX ADDITIONAL COMPLAINTS RELATED TO LEAKING CATHETERS FROM LOT 23F014D. OF THESE, THREE COULD NOT BE CONFIRMED DUE TO MISSING SAMPLES, WHILE THE REMAINING THREE WERE ATTRIBUTED TO THE APPLICATION OF EXCESSIVE TENSILE FORCE AND THE USE OF ALCOHOL-BASED DISINFECTANTS, RATHER THAN A MANUFACTURING ISSUE. CORRECTIVE ACTION: AS EACH CATHETER IS FLOW AND LEAK TESTED DURING PRODUCTION, AND THE CATHETER WORKED WELL FOR 8 DAYS BEFORE THE LEAKAGE OCCURRED, WE DO NOT BELIEVE THIS DEFECT IS MANUFACTURING RELATED. ANY MANUFACTURING PROBLEMS THAT WOULD LEAD TO A LEAK WOULD BE DETECTED BY THE USER WHEN INITIALLY FLUSHING THE CATHETER. THEREFORE, NO FURTHER CORRECTIVE ACTION WAS INITIATED BY QUALITY.

Additional Manufacturer Narrative · 0

THE RESULTS OF THIS INVESTIGATION ARE STILL PENDING AND WILL BE REPORTED TO THE FDA WITHIN THIRTY DAYS OF ITS CONCLUSION VIA A FOLLOW-UP MDR.

Description of Event or Problem · 0

DRESSING LIFTING, 0.5CM OF CATH DISLODGED, SORBAVIEW DRESSING. NEW LINE WAS PLACED.

Description of Event or Problem · 0

DRESSING LIFTING, 0.5CM OF CATH DISLODGED, SORBAVIEW DRESSING. NEW LINE WAS PLACED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1266473 PREMICATH INTRAVASCULAR CATHETER LJS VYGON USA 1261.203A 23F014D

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown